mounjaro glp 1 gip The OCULUS trial settles the longstanding debate: whether to continue to hold GLP-1/GIP agonists like before upper endoscopy. These were the results👇 📸: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2846278 Mounjaro®

Concerns Regarding Injections: When injecting BPC-157 or TB-500, there is a risk of injection site reactions such as pain, redness, or swelling

Some practitioners do combine Dihexa and Cerebrolysin, as their mechanisms are complementary Cerebrolysin offers broad multi-target neurotrophic support while Dihexa targets specific synaptogenesis

You puncture the vial, draw what you need, and the remaining solution stays pristine for the next time

Standard-dose tirzepatide may be a good fit for patients with more significant weight loss goals, stronger food cravings, prior limited response to semaglutide, or a preference for a dual GLP-1/GIP pathway